In line with this, Tano et al. reported that treatment of human breast cancer cells (MCF10A and MCF10CA1h) with an NMD-inducing Morpholino against the signal transducer and activator of transcription 3 (STAT3) significantly reduces expression of this oncogenic transcription factor [193]. Here, STAT3 is linked to breast cancer.